Retinopathy and microalbuminuria in type II diabetic patients by Manaviat, Masoud R et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
BMC Ophthalmology
Open Access Research article
Retinopathy and microalbuminuria in type II diabetic patients
Masoud R Manaviat*, Mohammad Afkhami and Mohammad R Shoja
Address: Diabetes Research Center, Jomhoori Blvd, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Email: Masoud R Manaviat* - mr_manaviat@yahoo.com; Mohammad Afkhami - afkhamiam@yahoo.com; 
Mohammad R Shoja - shoja99@yahoo.com
* Corresponding author    
Abstract
Background: The aim of this study was to identify risk factors for the development of retinopathy
and microalbuminuria and their correlation in type II diabetic patients.
Methods: In this cross-sectional study 590 patients suffering from diabetis type II were examined.
Fundoscopy was performed by practising ophthalmologist. The ratio of urinary albumin to
creatinine was assessed by clinitek 100 (Bayer corporation–USA). HbA1C, height and weight also
were measured.
Results: The overall prevalence of retinopathy was 39.3% (232 patients), 5.4% of which showed
to be prolifrative diabetic retinopathy (PDR). The diabetic retinopathy had significant inverse
correlation with body mass index (BMI) (P = 0.02). HbA1C was higher in patients with PDR (mean
= 10.5%) than in patients with no signs of retinopathy (mean = 9.5%) and this difference was
statistically significant (P = 0.001). The prevalence of microalbuminuria was 25.9% while 14.5% of
the patients revealed to have macroalbuminuria. As expected, diabetic retinopathy and renal
involvement were highly positively correlated. (P = 0.001).
Conclusion: Microalbuminuria is associated with diabetic retinopathy in type II diabetic patients
and is a reliable marker of retinopathy.
Background
Diabetes mellitus is one of the most common metabolic
diseases in which either the hormone insulin is lacking or
the body's cells are insensitive to insulin effects. The
multi-system effects of diabetes such as retinopathy,
nephropathy, neuropathy and cardiovascular diseases are
considered important impinging on the public health.
Diabetic retinopathy is one of the leading causes of blind-
ness in the world that increases the chance of loosing the
sight about 25 times higher compared to normal individ-
uals [1]. Using new surgical and medical techniques, the
incidence of blindness can be reduced up to 90% [2].
Decrease in visual acuity in diabetic retinopathy is either
associated with maculopathy or proliferative complica-
tions of it. Many studies have been undergone to find out
the precipitated factors of retinopathy such as duration
and type of diabetes, hyperglycemia, pregnancy, change in
hormonal level, genetics and microalbuminuria.
The occurrence of microalbuminuria in diabetes type I is
highly predictive of renal and cardiovascular diseases
whereas in type II less association of these is observed [3].
The purpose of this study is to evaluate the incidence of
microalbuminuria, macroalbuminuria and their relation
to diabetic retinopathy and other risk factors such as
hyperglycemia, hypertension in diabetes type II.
Published: 01 July 2004
BMC Ophthalmology 2004, 4:9 doi:10.1186/1471-2415-4-9
Received: 20 November 2003
Accepted: 01 July 2004
This article is available from: http://www.biomedcentral.com/1471-2415/4/9
© 2004 Manaviat et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL. BMC Ophthalmology 2004, 4:9 http://www.biomedcentral.com/1471-2415/4/9
Page 2 of 4
(page number not for citation purposes)
Methods
This cross sectional study was carried out on the patients
with diabetes type II who had referred to Yazd Center of
Diabetes Research between the years 2000 to 2001.
The diagnosis of diabetes mellitus was performed accord-
ing to the World Health Organization (WHO) criteria
which had been reported by WHO study group (1985).
Subsequent to completing preliminary questionnaires
that included personal data, the patients' ophthalmologic
examination and laboratory tests were also completed.
Clinitek 100 (made by Bayer Corporation-Elkhart, IN
46515, USA) was used to measure microalbuminuria.
Three urine samples were taken during three to six
months and if two samples were positive, microalbu-
minuria was affirmed. (The device shows the ratio of albu-
min to creatinine in mg/g). If the ratio was less than 30,
the patient was normoalbuminuric. Ratios between 30–
300 mg/g were indicative of microalbuminuria and above
300 mg/g revealed macroalbuminuria.
Detailed assessment was completed to exclude other pos-
sible causes of microalbuminuria. Ophthalmologic exam-
ination including visual acuity (by means of snellen
charts), intraocular pressure (using Applanation Tonome-
try), fundoscopy (utilizing slit lamp and contact lenses)
and indirect ophthalmoscopy were also completed. If
required, fluorescein angiography was ordered. All the rel-
evant examinations were completed by an ophthalmolo-
gist and the patients were categorized according to the
degree of their retinopathy.
No retinopathy
Mild Nonproliferative Diabetic Retinopathy (NPDR)
Moderate NPDR
Severe NPDR
Proliferative diabetic retinopathy (PDR)
Five minutes after resting in the sitting position, the
patients' blood pressure was measured by mercury Sphyg-
momanometer. BP ≥ 135/80 mmHg was considered
abnormal. Patient's medications including hypertensive
drugs were also recorded. Body Mass Index (BMI) was also
documented. HbA1c was ordered and finally the data
were analyzed by chi-square and Fischer exact tests. P val-
ues of <0.05 were considered significant.
Results
A total of 590 patients (346 females and 244 males) were
included in this study. The existing methods of treatment
at the first visit focused on dietary habits alone for 56
patients, oral agents for 453 patients, insulin for 61
patients and insulin plus oral agents for 7 patients. The
age average was 54.9 ± 10.2 and the patients' duration of
diabetes was between 1 to 32 years (Mean = 10.2 ± 6.6).
Duration of diabetes was less than 5 years in 30% of the
patients, between 6–10 years in 30% and more than 10
years in 40% of them. Duration of diabetes was a strong
predictor of severity of retinopathy (p = 0.001) (Table 1).
39.3 % of the patients had retinopathy to some degrees,
19.2% had mild NPDR, 12% moderate NPDR, 2.7%
severe NPDR and 5.4% had PDR. Fifty-two patients
(13.3%) had Clinically Significant Macular Edema
(CSME). About 200 of patients had BP ≥ 135/80 mmHg,
173 of whom were under treatment with antihypertensive
drugs. There was no significant relationship (p = 0.37)
between high blood pressure and different degrees of
retinopathy. Gender also had no significant correlation
with severity of retinopathy (p = 0.31).
The relationship between different types of retinopathy
and risk factors such as HbA1C, FBS, BMI and age revealed
to be significant (Table 2).
Examination of urine samples in 330 subjects (59.5%)
showed normal range of albumin excretion (normoalbu-
minuria). 25.9% of the patients, were microalbuminuric
and 14.5% had macroalbuminuria. Table 3 shows signifi-
cant relationship between different grades of retinopathy
and albuminuria (p = 0.001).
Discussion
Numerous studies were carried out to determine the prev-
alence of retinopathy and albuminuria in diabetes Type 2.
These studies yielded different rates between 16 to 53.4%
for retinopathy [4-9]. Our study showed the prevalence
rate of 39.3% which is somewhere in median range. The
variation in rate could be as a result of different methods
used in those studies, the population and or the races
involved, or variation in controlling blood sugar level.
The prevalence of microalbuminuria and macroalbu-
minuria in our study was 25.9% and 14.5% respectively.
Parving et al reported the incidence rate of 22% of micro-
albuminuria in diabetes type 2 [10]whereas Lunetta
reported the incidence rate of 15% [4]. The above-men-
tioned studies show that there is a significant relationship
between the degree of retinopathy and albuminuria.
However there are few studies opposing such relationship.
Erasmus et al showed that in 113 patients suffering from
NIDDM, the incidence rate of microalbuminuria was as
high as 54% among males and 59% among females. Prev-
alence of retinopathy and hypertention was 16% and 41%BMC Ophthalmology 2004, 4:9 http://www.biomedcentral.com/1471-2415/4/9
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respectively. They concluded that microalbuminuria may
not predict retinopathy and occurs independently from
either glycaemic control or elevated blood pressure levels
[8]. The population chosen for the study influences the
different incidences achieved in various studies. For exam-
ple, 5–6% of normal nondiabetic individuals in the
united Kingdom and the united States of America have
microalbuminuria whereas in South Korea this value is
12.2% and in Finland 30–35% [11].
Our study showed that in addition to HbA1c, BMI, and
length of illness, microalbuminuria is a contributing fac-
tor in the degree of retinopathy (p = 0.001) and this cor-
relation can be explained by the common mechanism
involved in tissue damage by all those factors. In addition
to blood sugar level and blood pressure, there are also
other factors which damage vessels in retina and kidney.
For example, Klein et al showed that microalbuminuria
could be seen in 29.2% of insulin taking patients and 22%
of non-insulin dependent patients. Therefore, insulin can
also have a role in nephropathy [12].
In a study on 497 normal nondiabetic cases who were
above 40 years in Seoul, Kim et al, after regression analy-
sis, reported that fasting plasma level of insulin and systo-
lic blood pressure have independent correlation with
micoralbuminuria [11]. Besides common mechanisms,
renal damage may accelerate retinopathy which is associ-
ated with increased blood pressure and serum levels of
fibrinogen and lipoproteins.
Also microalbuminuria has positive correlation with inci-
dence of coronary heart disease [4,13]. Albuminuria also
has been considered as a predictor of diabetic retinopathy
and coronary heart disease. Thus excretion of albumin in
urine can be regarded as a sign of kidney involvement and
Table 1: Relationship between duration of diabetes and different types of retinopathy
Duration of 
retinopathy
Grade of retinopathy
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Total
1–5 157 (90.2%) 10 (5.7%) 6 (3.4%) 0 (.0%) 1 (.6%) 174 100%
6–10 122 (69.3%) 36 (20.5%) 13 (7.4%) 1 (.6%) 4 (2.3%) 176 100%
11–15 52 (49.1%) 29 (27.4%) 17 (16.0%) 5 (4.7%) 3 (2.8%) 106 100%
16–32 22 (17.1%) 38 (29.5%) 35 (27.1%) 10 (7.8%) 24 (18.6%) 129 100%
Total 353 (60.3% 113 (19.3%) 71 (12.1%) 16 (2.7%) 32 (5.5%) 585 100%
Table 2: The relationship between retinopathy and its risk factors
Risk factors p value
HbA1c (%) 0.001
Fasting Blood sugar (mg/dl) 0.001
Body Mess Index (kg/m2)0 . 0 2 8
Age (years) 0.014
Table 3: Relationship between different types of retinopathy and albuminuria
Albuminuria Grade of retinopathy
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Total
Normoalbuminuria 239 (72.4%) 57 (17.3%) 26 (7.9%) 1 (0.3%) 7 (2.1%) 330 100%
Microalbuminuria 81 (56.6%) 27 (18.9%) 24 (16.8%) 4 (2.8%) 7 (4.9%) 143 100%
Macroalbuminuria 17 (21.3%) 21 (26.3%) 19 (23.8%) 9 (11.3%) 14 (17.5%) 80 100%
Total 337 (60.9%) 105 (19.0%) 69 (12.5%) 4 (2.5%) 28 (5.1%) 553 100%Publish with BioMed Central    and   every 
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can reflect generalized vessel damage throughout the
body. Further prospective studies should be carried out to
evaluate the effect of lowering albumin excretion on the
reduction of blood vessel damage.
Conclusion
Microalbuminuria is associated cross sectionaly with the
presence of retinopathy in porsons with diabetes type II.
These data suggest that microalbuminuria may be a
marker for the risk of proliferative retinopathy develop-
ment. If longitudinal studies confirm these findings, dia-
betic patients who have microalbuminuria may benefit
from close ophthalmologic follow up.
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